Key result
Fourteen days of smoking abstinence led to rapid and reproducible reductions in biomarkers of exposure, LTE4, 2,3-d-TXB2, WBC, and neutrophil counts compared to baseline.
Why the study?
Because adverse health impacts of smoking can persist for years after cessation, Biomarkers of Potential Harm are needed for interim evaluations of the benefits of smoking cessation or switching to lower-risk products.
Does 14-day smoking abstinence improve biomarkers of exposure and potential harm in chronic smokers?
Cohort (n=70)
Does 14-day smoking abstinence improve biomarkers of exposure and potential harm in chronic smokers?
A 14-day smoking abstinence rapidly reduces biomarkers of exposure, platelet function, oxidative stress, and inflammation, supporting their use in evaluating smoking cessation interventions.
Answers are grounded in this paper and cite their sources.
Supports biomarker monitoring in cessation programs; leaves open links to long-term cardiovascular outcomes.
: Chronic cigarette smoking is a major risk factor for many serious diseases. While complete cessation of smoking is the best option to reduce harm from smoking, adverse impacts of smoking on health could persist for several years after cessation. Therefore, Biomarkers of Potential Harm (BoPH) are useful in interim evaluations of the beneficial effects of smoking cessation or switching to potentially lower-risk tobacco products. A 14-day smoking abstinence study was conducted under clinical confinement conditions and enrolled 70 subjects into younger (24–34 years, n = 33) and older (35–60 years, n = 37) age cohorts. Biomarkers of Exposure (BoE), which indicate exposure to nicotine and other toxicants, were measured at baseline, 7 and 14 days. Several BoPH including previously identified eicosanoids (leukotriene 4 (LTE4) and 2,3-dinor thromboxane 2 (2,3-d-TXB2) and others were evaluated. Significant declines in BoE, LTE4, 2,3-d-TXB2, neutrophils, WBC and select RBC, and arterial blood gas parameters were observed in both age cohorts at Days 7 and 14 compared to baseline, while other BoPH (e.g., FeNO) showed age-related effects. Rapid and reproducible reductions in LTE4, 2,3-d-TXB2 WBC, and neutrophil counts were consistently detected following smoking abstinence, indicating the value of these markers as useful BoPH.
No takes yet. Share an insight, caveat, or question.
Makena et al. (2023) conducted a cohort in Chronic cigarette smoking (n=70). Smoking abstinence vs. Baseline was evaluated on Changes in Biomarkers of Exposure (BoE) and Biomarkers of Potential Harm (BoPH) including LTE4 and 2,3-d-TXB2. Fourteen days of smoking abstinence led to rapid and reproducible reductions in biomarkers of exposure, LTE4, 2,3-d-TXB2, WBC, and neutrophil counts compared to baseline.
Synapse has enriched 10 related papers. Consider them for comparative context: